Nanomedicine. 2015;10(2):321-341. Delivery: "Go where we want." The contrast agent must be able to be delivered in vivo and transported to the site of interest. Nontoxic: "Do no harm along the way." ...
Ferabright is the first and only iron-based contrast agent for MRI in the brainWoburn, MA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that FerabrightTM ...
Key market opportunities include rising demand for advanced contrast agents due to increasing cardiovascular and vascular ...
This growth is primarily driven by the increasing number of diagnostic imaging procedures, continuous technological advancements in imaging ...
An imaging process that today is used mainly in research labs could potentially detect early-stage lung disease if developed for use in hospitals and clinics, a new research study shows. Researchers ...
Please provide your email address to receive an email when new articles are posted on . With this detection ability, asthma and COPD could be more clearly displayed to clinicians during screening, ...
The need for diagnostic imaging services continues to grow at a rate of 3-4% annually, but many medical facilities, ...
Techniques that exploit the phase of X-rays, not just their absorption, have the potential to transform X-ray imaging in hospitals, reports Jude Dineley Improved imaging Marian Willner from the ...
Contrast-induced nephropathy is rare. It results from exposure to contrast dyes during certain imaging tests and cardiology procedures. People living with diabetes or advanced kidney disease may be at ...
† The mass of AuNPs delivered per cell was estimated from the reported number of AuNPs per cell, assuming perfectly spherical, monosized AuNPs and the bulk density of gold (19.3 g/cm3). ‡ Maximum ...